TY - JOUR
T1 - Involvement of ventral tegmental area ionotropic glutamate receptors in the expression of ethanol-induced conditioned place preference
AU - Pina, Melanie M.
AU - Cunningham, Christopher L.
N1 - Funding Information:
Research reported in this paper was supported by the National Institutes of Health under award numbers R01AA007702 and T32AA007468 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A Scholar Award from the ARCS Foundation Portland Chapter and a Graduate Scholarship from the OHSU-Vertex Partnership provided additional support (MMP). Experiments reported here comply with the current laws of the United States.
Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2016/10/15
Y1 - 2016/10/15
N2 - The ventral tegmental area (VTA) is a well-established neural substrate of reward-related processes. Activity within this structure is increased by the primary and conditioned rewarding effects of abused drugs and its engagement is heavily reliant on excitatory input from structures upstream. In the case of drug seeking, it is thought that exposure to drug-associated cues engages glutamatergic VTA afferents that signal directly to dopamine cells, thereby triggering this behavior. It is unclear, however, whether glutamate input to VTA is directly involved in ethanol-associated cue seeking. Here, the role of intra-VTA ionotropic glutamate receptor (iGluR) signaling in ethanol-cue seeking was evaluated in DBA/2J mice using an ethanol conditioned place preference (CPP) procedure. Intra-VTA iGluRs α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPAR)/kainate and N-methyl-D-aspartate (NMDAR) were blocked during ethanol CPP expression by co-infusion of antagonist drugs 6,7-dinitroquinoxaline-2,3-dione (DNQX; AMPA/kainate) and D-(−)-2-Amino-5-phosphonopentanoic acid (AP5; NMDA). Compared to aCSF, bilateral infusion of low (1 DNQX + 100 AP5 ng/side) and high (5 DNQX + 500 AP5 ng/side) doses of the AMPAR and NMDAR antagonist cocktail into VTA blocked ethanol CPP expression. This effect was site specific, as DNQX/AP5 infusion proximal to VTA did not significantly impact CPP expression. An increase in activity was found at the high but not low dose of DNQX/AP5. These findings demonstrate that activation of iGluRs within the VTA is necessary for ethanol-associated cue seeking, as measured by CPP.
AB - The ventral tegmental area (VTA) is a well-established neural substrate of reward-related processes. Activity within this structure is increased by the primary and conditioned rewarding effects of abused drugs and its engagement is heavily reliant on excitatory input from structures upstream. In the case of drug seeking, it is thought that exposure to drug-associated cues engages glutamatergic VTA afferents that signal directly to dopamine cells, thereby triggering this behavior. It is unclear, however, whether glutamate input to VTA is directly involved in ethanol-associated cue seeking. Here, the role of intra-VTA ionotropic glutamate receptor (iGluR) signaling in ethanol-cue seeking was evaluated in DBA/2J mice using an ethanol conditioned place preference (CPP) procedure. Intra-VTA iGluRs α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPAR)/kainate and N-methyl-D-aspartate (NMDAR) were blocked during ethanol CPP expression by co-infusion of antagonist drugs 6,7-dinitroquinoxaline-2,3-dione (DNQX; AMPA/kainate) and D-(−)-2-Amino-5-phosphonopentanoic acid (AP5; NMDA). Compared to aCSF, bilateral infusion of low (1 DNQX + 100 AP5 ng/side) and high (5 DNQX + 500 AP5 ng/side) doses of the AMPAR and NMDAR antagonist cocktail into VTA blocked ethanol CPP expression. This effect was site specific, as DNQX/AP5 infusion proximal to VTA did not significantly impact CPP expression. An increase in activity was found at the high but not low dose of DNQX/AP5. These findings demonstrate that activation of iGluRs within the VTA is necessary for ethanol-associated cue seeking, as measured by CPP.
KW - AMPA
KW - CPP
KW - DBA/2J
KW - Glutamate
KW - NMDA
KW - VTA
UR - http://www.scopus.com/inward/record.url?scp=84978194123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978194123&partnerID=8YFLogxK
U2 - 10.1016/j.bbr.2016.06.063
DO - 10.1016/j.bbr.2016.06.063
M3 - Article
C2 - 27378337
AN - SCOPUS:84978194123
SN - 0166-4328
VL - 313
SP - 23
EP - 29
JO - Behavioural Brain Research
JF - Behavioural Brain Research
ER -